Weight loss jabs like Ozempic could ‘cut risk of heart attack and stroke’ ...Tech & Science Daily

Listen to Tech & Science Daily here: pod.fo/e/23b9cf
A study claims that weight loss jabs could reduce the risk of heart attack and stroke in obese people, regardless of the amount of weight they lose while on the drug.
The team led by Professor John Deanfield from University College London, used data from the Select trial, which was conducted by semaglutide manufacturer Novo Nordisk, and involved over 17,000 adults over the age of 45 from 41 countries.
Subscribe to the Evening Standard: bit.ly/Subscribe-to-Evening-S...
for latest breaking news from the UK, US and around the world, plus podcasts and features.
Evening Standard on socials:
Check out our full video catalog: / londoneveningstandard
Videos, daily editorial and more: www.standard.co.uk/
Like us on Facebook: www. eveningstandard
Follow us on Twitter: / eveningstandard
and Instagram: / evening.standard

[@guff9567]

From your friendly Gates Foundation